Treatment with exenatide BID and QW for 30 weeks was associated with favourable lipid subclass changes Meeting Abstract

Industry Collaboration

cited authors

  • Chilton, R.; Toth, P.; Ramirez, G.; Cobble, M.; Walsh, B.; Chiquette, E.

fiu authors

publication date

  • September 2011

published in

category

volume

  • 54

research area